André Habel

Title: The Innovative Contributions of Andre Habel

Introduction

Andre Habel is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of methods and polypeptides related to pathogenic viruses. With a total of 4 patents, her work has the potential to impact medical research and treatment.

Latest Patents

Habel's latest patents include groundbreaking inventions. One of her patents is titled "Antigens encoded by alternative reading frames from pathogenic viruses." This invention discloses polypeptides that start with a methionine amino acid residue, comprise an antigenic determinant, and contain more than 7 amino acid residues. Additionally, she has developed a "Method for isolating hepatitis C virus peptides." This method outlines a process for isolating Hepatitis C Virus peptides that bind to MHC/HLA molecules, detailing the steps for providing a pool of HCV-peptides and detecting binding capacities.

Career Highlights

Andre Habel is currently associated with Intercell AG, a company focused on innovative vaccine development and biotechnology. Her work at Intercell AG has allowed her to explore and develop her inventions further, contributing to advancements in the field.

Collaborations

Habel has collaborated with notable colleagues, including Frank Mattner and Michael Buschle. These collaborations have likely enhanced her research and development efforts, fostering innovation in her projects.

Conclusion

Andre Habel's contributions to biotechnology through her patents and work at Intercell AG highlight her role as an influential inventor. Her innovative approaches to understanding and isolating viral peptides are paving the way for future advancements in medical research and treatment.